NIH Weekly Funding Opportunities and Policy Notices
Notice NOT-DA-22-061 from the NIH Guide for Grants and Contracts
Funding Opportunity PAR-22-189 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) supports applications to develop and implement investigator-initiated single site clinical trials including efficacy, comparative effectiveness, pragmatic and/or implementation research clinical trials. These trials may include ones that test different therapeutic, behavioral, and/or prevention strategies. Trials for which this FOA applies must be relevant to the research mission of the NHLBI and meet the NIH definition of a clinical trial (see NOT-OD-15-015). For additional information about the mission, strategic vision, and research priorities of the NHLBI, applicants are encouraged to consult the NHLBI website.This FOA will utilize a bi-phasic, milestone-driven mechanism of award. The objective of the application is to present the scientific rationale for the clinical trial and a comprehensive scientific and operational plan that describes it. The application should address project management, subject recruitment and retention, performance milestones, scientific conduct of the trial, and dissemination of results. The multiple PD/PI model is strongly encouraged but not required. Applicants are encouraged to include a PD/PI with expertise in biostatistics, clinical trial design, and coordination.
Notice NOT-HD-22-014 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-HD-23-026 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites submission of Program Project (P01) applications to support integrated, multi-project research programs that address HIV scientific areas relevant to the NICHD mission as a well-defined, central research focus or objective.
Notice NOT-PM-22-002 from the NIH Guide for Grants and Contracts
Notice NOT-AT-22-024 from the NIH Guide for Grants and Contracts
Notice NOT-CA-22-038 from the NIH Guide for Grants and Contracts
Notice NOT-NS-23-003 from the NIH Guide for Grants and Contracts
Notice NOT-NS-23-004 from the NIH Guide for Grants and Contracts
Notice NOT-OD-22-138 from the NIH Guide for Grants and Contracts
Notice NOT-OD-22-120 from the NIH Guide for Grants and Contracts
Notice NOT-TW-22-001 from the NIH Guide for Grants and Contracts
Funding Opportunity PAR-22-186 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support hypothesis-generating research in transgender people with the objective of characterizing the biological and immunological impact of the interventions (hormones, drugs and surgical) used for gender reassignment and their impact on susceptibility to HIV and other sexually transmitted infections (STI).
Notice NOT-GM-22-037 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-NS-22-036 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) is designed to support integrated efforts of three or more (up to six) PDs/PIs to pursue bold, impactful, and challenging research in any area within the scope of the NINDS mission. The research approach should be interdisciplinary in nature, and the research teams are expected to establish a common goal that requires collaboration, synergy, and managed team interactions. Proposed research should not represent a collection of individual efforts or parallel projects. This program is distinct from the NINDS P01 in that it will support a cohesive, single, well-integrated research plan with a singular focus, one set of aims, and a budget without subprojects. Teams are encouraged to consider transformative objectives with defined 5-year outcomes.
Notice NOT-OD-22-126 from the NIH Guide for Grants and Contracts
Notice NOT-HD-22-023 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-MH-22-180 from the NIH Guide for Grants and Contracts. The goal of this initiative is to support research to improve the mental health of mobile populations, such as refugees, internally displaced persons, and migrants through improved diagnosis, prevention, and treatment approaches. Of specific interest is research that addresses the mental health care of priority populations such as children and youth, people with serious mental illness, sexual and gender minorities, people with disabilities, and separated families.
Notice NOT-CA-22-087 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-NS-22-056 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement invites applications from experienced investigators seeking to conduct exploratory clinical trials designed to test new treatments for patients with Lewy Body Dementia (LBD). Applicants may propose to conduct either Phase I or Phase II clinical trials depending on the developmental stage of the potential therapeutic, but all trials must include patients with LBD. Proposed therapies may include novel medications or devices, or existing treatments that are potentially beneficial but not currently approved for use in patients with LBD. Treatments intended to prevent or delay disease progression in LBD patients, as well as therapies to alleviate existing motor or non-motor clinical symptoms, are of interest.